Ironwood Pharmaceuticals ...

1.47
0.01 (0.68%)
At close: Mar 27, 2025, 3:59 PM
1.51
3.07%
After-hours: Mar 27, 2025, 07:55 PM EDT

Ironwood Pharmaceuticals Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06
Revenue 351.41M 442.74M 410.6M 413.75M 389.52M 428.41M 346.64M 298.28M 273.96M 149.56M 76.44M 22.88M 150.25M 65.87M 43.86M 36.1M 22.22M 10.46M 3.14M
Cost of Revenue n/a 104.78M 1.42M 1.52M 3.14M 23.88M 32.75M 19.41M 1.87M 12K 25.58M 7.2M 965K n/a n/a n/a n/a n/a 3.14M
Gross Profit 351.41M 337.95M 409.18M 412.23M 386.39M 404.54M 313.89M 278.87M 272.09M 149.54M 50.85M 15.68M 149.28M 65.87M 43.86M 36.1M 22.22M 10.46M n/a
Operating Income 94.85M -945.43M 250.34M 232.26M 142.94M 120.12M -238.89M -77.39M -51.87M -102.09M -169.37M -252M -72.76M -66.14M -60.77M -72.77M -55.92M -57.62M -39.59M
Interest Income 4.47M 18.97M 9.5M 726K 1.5M 2.86M 2.99M 2.11M 1.17M 443K 257K 192K 197K 456K 614K 243K 2.12M 4.12M 2.53M
Pretax Income 66.28M -948.07M 252.42M 200.66M 108.86M 58.94M -282.37M -116.94M -81.71M -142.67M -189.62M -272.81M -72.62M -64.85M -59.35M -73.61M -55.03M -53.16M -37.28M
Net Income 130.75M -1B 175.06M 528.45M 106.18M -15.31M -282.37M -116.94M -81.71M -142.67M -189.62M -272.81M -72.62M -64.85M -52.98M -71.19M -53.87M -52.75M -37.18M
Selling & General & Admin 144.01M 158.31M 115.99M 111.13M 140M 172.45M 241.29M 233.12M 173.28M 125.25M 118.33M 123.23M 92.54M 45.92M 27.17M 23.98M 18.33M 10.83M 5.93M
Research & Development 109.95M 116.08M 44.27M 70.41M 88.06M 115.04M 166.5M 148.23M 139.49M 108.75M 101.89M 102.38M 113.47M 86.09M 77.45M 84.89M 59.81M 57.25M 35.54M
Other Expenses n/a 1.01B n/a n/a 24K 514K 8.11M 6.21M 981K 17.64M 661K 42.07M 16.03M n/a n/a 23.98M 18.33M 10.83M n/a
Operating Expenses 253.97M 1.28B 160.26M 181.54M 228.06M 287.49M 415.9M 387.56M 313.75M 233.99M 220.22M 267.68M 222.04M 132.01M 104.62M 108.87M 78.14M 68.08M 41.48M
Interest Expense -33.03M 21.63M 7.6M 31.15M 29.48M 36.6M 34.73M 34.26M 37.98M 30.65M 21.17M 21M 59K 63K 196K 474K 334K 263K 217K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 256.56M 1.39B 160.26M 181.54M 231.2M 311.37M 448.66M 406.97M 315.62M 234M 245.81M 274.88M 223.01M 132.01M 104.62M 108.87M 78.14M 68.08M 42.73M
Income Tax -64.47M 83.49M 77.36M -327.79M 2.69M 74.26M -5.75M 34.26M 37.98M 19.02M 8.58M -11.73M -11.32M 3K -2.94M -296K -823K -145K n/a
Shares Outstanding (Basic) 159.71M 155.44M 154.37M 162.25M 159.43M 156.02M 152.63M 148.42M 144.93M 142.16M 136.81M 115.85M 106.4M 99.88M 89.65M 7.12M 6.89M 7.12M 94.91M
Shares Outstanding (Diluted) 160.23M 155.44M 186.31M 164.42M 160.66M 156.02M 152.63M 148.99M 145.91M 142.16M 136.81M 115.85M 106.4M 99.88M 89.65M 75.57M 6.89M 75.57M 94.91M
EPS (Basic) 0.82 -6.45 1.13 3.26 0.67 -0.1 -1.85 -0.79 -0.56 -1 -1.39 -2.35 -0.68 -0.65 -0.59 -10 -7.82 -7.41 -0.39
EPS (Diluted) 0.82 -6.45 0.94 3.21 0.66 -0.1 -1.85 -0.78 -0.56 -1 -1.39 -2.35 -0.68 -0.65 -0.59 -0.94 -7.82 -0.7 -0.39
EBITDA 94.85M -924.86M 261.44M 233.33M 141.9M 101.13M -144.45M -33.12M -31.3M -99.94M -156.12M -240.08M -61.24M -54.79M -53M -67.28M -51.85M -51.17M -35.8M
Depreciation & Amortization n/a 1.57M 1.42M 1.52M 3.56M 5.58M 11.97M 14.62M 11.26M 11.63M 12.33M 11.73M 11.32M 10M 6.16M 5.25M 2.85M 1.73M 1.26M